StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Last viewed:
abus
Prices are updated after-hours
Sector
Health Technology
1
Industry
Biotechnology
1
Name
Arbutus Biopharma Corporation
1
Symbol
Abus
1
Acer
1
Adsk
1
Adtx
1
Agfs
1
Agys
1
Akts
1
Aktx
1
Aku
1
Algn
1
Algt
1
Apei
1
Apm
1
Appn
1
Aso
1
Aste
1
Atif
1
Atsg
1
Aub
1
Avdl
1
Avid
1
Azpn
1
Banr
1
Bbi
1
Bcor
1
Bgne
1
Bhat
1
Bioc
1
Bldp
1
Blin
1
Bmrn
1
Bpmc
1
Cac
1
Car
1
Cash
1
Cass
1
Cbay
1
Cbfv
1
Ccmp
1
Ccoi
1
Ccrn
1
Ccxi
1
Cdmo
1
Cdna
1
Cdns
1
Celh
1
Cers
1
Cgnx
1
Chef
1
Chrs
1
Clar
1
Clgn
1
Clro
1
Clsk
1
Cnce
1
Cort
1
Cpss
1
Crsr
1
Crvl
1
Csii
1
Tags
Hepatitis
1
Injection
1
Venue
Nasdaq
1
Ipo Year
N::a
1
Country
United States
1
Sec Forms
10-k
1
10-k::a
1
10-q
1
3
1
4
1
424b5
1
8-k
1
Corresp
1
Ct Order
1
Def 14a
1
Defa14a
1
Effect
1
S-3
1
S-8
1
Sc 13g
1
Sc 13g::a
1
Upload
1
Sec Forms Date
2021 - 08 - 05
1
2021 - 07 - 14
1
2021 - 07 - 07
1
2021 - 07 - 06
1
2021 - 06 - 29
1
2021 - 06 - 28
1
2021 - 06 - 07
1
2021 - 06 - 01
1
2021 - 05 - 05
1
2021 - 04 - 08
1
2021 - 04 - 01
1
2021 - 03 - 16
1
2021 - 03 - 04
1
2021 - 02 - 26
1
2021 - 02 - 17
1
2021 - 02 - 16
1
2021 - 02 - 12
1
2021 - 02 - 10
1
2021 - 02 - 01
1
2021 - 01 - 25
1
2020 - 12 - 16
1
2020 - 12 - 10
1
2020 - 11 - 16
1
2020 - 11 - 05
1
2020 - 10 - 22
1
2020 - 10 - 21
1
2020 - 09 - 25
1
2020 - 09 - 15
1
2020 - 09 - 03
1
2020 - 09 - 01
1
2020 - 08 - 28
1
2020 - 08 - 27
1
2020 - 08 - 10
1
2020 - 08 - 07
1
2020 - 07 - 27
1
2020 - 07 - 24
1
2020 - 07 - 23
1
2020 - 07 - 16
1
2020 - 06 - 24
1
2020 - 06 - 01
1
2020 - 05 - 18
1
2020 - 05 - 11
1
2020 - 04 - 24
1
2020 - 03 - 26
1
2020 - 03 - 06
1
2020 - 03 - 05
1
2020 - 02 - 19
1
2020 - 02 - 14
1
2020 - 02 - 10
1
2020 - 01 - 13
1
2020 - 01 - 10
1
2020 - 01 - 08
1
2019 - 12 - 27
1
2019 - 12 - 23
1
2019 - 12 - 09
1
2019 - 11 - 06
1
2019 - 11 - 05
1
2019 - 10 - 03
1
2019 - 08 - 26
1
2019 - 08 - 20
1
News In 15d
1
1
News In 30d
2
1
Created At
2020 - 11 - 27
1
Abus
Nasdaq
2020 - 09 - 01
Arbutus Biopharma Corporation
ABUS
|
$2.725
-0.18%
-0.18%
930K
|
Health Technology
(
0.0%
1d)
(
6.7%
1m)
(
-9.3%
1y)
(
-1.1%
2d)
(
-6.8%
3d)
(
-8.4%
7d)
(
Infinity%
volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 489,116,242
http://www.arbutusbio.com
Sec Filling
|
Patents
| 80 employees
ABUS
(US) Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.
hepatitis
injection
add to watch list
Paper trade
email alert is off
Press-releases
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
Published:
2024-04-18
(Crawled : 12:00)
- globenewswire.com
ABUS
|
$2.725
-0.18%
-0.18%
930K
|
Health Technology
|
-6.85%
|
O:
-5.82%
H:
0.0%
C:
0.0%
first
report
update
financial
results
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Published:
2024-04-04
(Crawled : 12:30)
- globenewswire.com
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
0.2%
|
O:
1.46%
H:
3.2%
C:
-0.41%
ABUS
|
$2.725
-0.18%
-0.18%
930K
|
Health Technology
|
8.37%
|
O:
16.73%
H:
6.14%
C:
2.39%
patent
construction
biopharma
ongoing
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
Published:
2024-03-20
(Crawled : 12:00)
- globenewswire.com
ABUS
|
$2.725
-0.18%
-0.18%
930K
|
Health Technology
|
7.51%
|
O:
-1.58%
H:
3.05%
C:
2.41%
year
update
financial
results
Lipid-Nanoparticle Based Genomic Medicines Market worth $32.5 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published:
2024-03-18
(Crawled : 14:00)
- prnewswire.com
CVAC
|
$2.44
0.0%
790K
|
Health Technology
|
-26.06%
|
O:
0.0%
H:
0.0%
C:
-2.73%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-6.13%
|
O:
0.48%
H:
1.18%
C:
0.08%
ABUS
|
$2.725
-0.18%
-0.18%
930K
|
Health Technology
|
3.82%
|
O:
0.38%
H:
0.38%
C:
-3.42%
report
genomic
market
Arbutus to Participate in Two Upcoming Investor Conferences
Published:
2024-03-08
(Crawled : 12:30)
- globenewswire.com
ABUS
|
$2.725
-0.18%
-0.18%
930K
|
Health Technology
|
-1.09%
|
O:
0.18%
H:
0.0%
C:
0.0%
Arbutus to Participate in Two Upcoming Investor Conferences - March 8, 2024
Published:
2024-03-08
(Crawled : 14:30)
- biospace.com/
ABUS
|
$2.725
-0.18%
-0.18%
930K
|
Health Technology
|
-1.09%
|
O:
0.18%
H:
0.0%
C:
0.0%
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Published:
2024-02-29
(Crawled : 12:30)
- globenewswire.com
ROIV
|
$10.46
0.97%
0.96%
4.7M
|
Manufacturing
|
-10.67%
|
O:
1.2%
H:
0.34%
C:
-3.46%
ABUS
|
$2.725
-0.18%
-0.18%
930K
|
Health Technology
|
-6.53%
|
O:
-1.37%
H:
0.0%
C:
-2.44%
year
update
financial
results
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
Published:
2024-02-15
(Crawled : 12:30)
- globenewswire.com
ABUS
|
$2.725
-0.18%
-0.18%
930K
|
Health Technology
|
-7.01%
|
O:
0.85%
H:
0.0%
C:
-1.36%
report
year
update
financial
results
Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
Published:
2024-01-08
(Crawled : 13:00)
- globenewswire.com
ABUS
|
$2.725
-0.18%
-0.18%
930K
|
Health Technology
|
12.86%
|
O:
3.32%
H:
3.21%
C:
-1.61%
update
financial
Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD
Published:
2023-11-09
(Crawled : 21:00)
- globenewswire.com
ABUS
|
$2.725
-0.18%
-0.18%
930K
|
Health Technology
|
51.11%
|
O:
1.67%
H:
0.0%
C:
-3.28%
hbv003
biopharma
collaboration
trial
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001447028-24-000029
4
2024-02-06
2024-02-01
Buy
A
380500
380500
0001447028-24-000029
4
2024-02-06
2024-02-01
Buy
A
95100
95100
0001447028-24-000028
4
2024-02-06
2024-02-01
Buy
A
403900
403900
0001447028-24-000028
4
2024-02-06
2024-02-02
Sell
S
4358
125542
0001447028-24-000028
4
2024-02-06
2024-02-01
Buy
A
101000
129900
Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
67%
33%
Top 10 Gainers
Last 48 Hours Insiders Buying
RXO
P
200000
|
$19.37
2.32%
0.0%
1M
|
n/a
|
23:00
RKT
P
380
|
$11.68
1.3%
0.17%
1.9M
|
Finance
|
22:30
HROW
P
29400
|
$10.43
-3.87%
-4.03%
680K
|
Health Technology
|
22:30
BCDA
P
2750
|
$0.377
-1.4%
97K
|
Health Technology
|
22:00
RMCF
|
$3.67
3.38%
3.27%
11K
|
Consumer Non-Durables
|
20:10
12 months watchlist earnings calendar